Fort Sam Houston, TX1 Active Studies

Spinal Cord Injury Clinical Trials in Fort Sam Houston, TX

Find 1 actively recruiting spinal cord injury clinical trials in Fort Sam Houston, TX. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
1,500
Enrolling

Recruiting Spinal Cord Injury Studies in Fort Sam Houston

About Spinal Cord Injury Clinical Trials in Fort Sam Houston

Spinal cord injury is damage to the spinal cord that causes loss of function, mobility, or sensation below the injury site. It can result in paraplegia or quadriplegia depending on the level of injury. Research is exploring regenerative therapies, electrical stimulation, and rehabilitation technologies.

There are currently 1 spinal cord injury clinical trials recruiting participants in Fort Sam Houston, TX. These studies are seeking a combined 1,500 participants. Research is being sponsored by Robert G. Grossman, MD. Clinical trial participation is free and participants receive study-related medical care at no cost.

Spinal Cord Injury Clinical Trials in Fort Sam Houston — FAQ

Are there spinal cord injury clinical trials in Fort Sam Houston?

Yes, there are 1 spinal cord injury clinical trials currently recruiting in Fort Sam Houston, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fort Sam Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Sam Houston research site will contact you about next steps.

Are clinical trials in Fort Sam Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Sam Houston studies also compensate for your time and travel.

What spinal cord injury treatments are being tested?

The 1 active trials in Fort Sam Houston are testing new therapies including novel drugs, biologics, and treatment approaches for spinal cord injury.

Data updated July 13, 2026 from ClinicalTrials.gov